contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  createdAt
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
    forum {
      threadUrl
    }
    defaultInstrument {
      symbol
      id
    }
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  createdAt
  changedAt
  isPremium
  authors {
    __typename
    name
    pageUrl
    id
  }
  companies {
    name
    pageUrl
    id
  }
  tags {
    name
    id
  }
  ... on Video {
    liveTime
    videoUrl
    videoEmbedUrl(location: "inderes")
  }
  ... on Webcast {
    liveTime
    videoUrl
    videoEmbedUrl(location: "inderes")
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        threadUrl
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        symbol
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
      researchContentUrl
      researchContent {
        title
        lang
        pdfUrl
        relatedContent {
          __typename
          ...PublishingDetails
          ...Reactions
          id
        }
        content {
          title
          lang
          htmlBody
          publishedAt
          createdAt
          changedAt
          isOutdated
          isPremium
        }
      }
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


optomed-plc-managers-transactions-leppanen

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

changedAt

Optomed operates in the medical technology sector. The company conducts research and development of specialized eye cameras. Development takes place of both hardware and software that are resold under different brands. Operations are held on a global level, with the largest presence in the Nordic market. Customers consist of research institutes and hospitals. The company has its headquarters in Oulu.

Håber de laver nogle nye aftaler derinde.                   finnishigamingevents.fi              Finnish Gaming Conference | Finnish iGaming Events    Finnish iGaming Events will be hosting the 1st Gaming Conference in Finland. This conference will gather regulators, government officials, investors, operators and providers to learn about the exciting forthcoming licensing gaming market...

En ganske speciel kommentar har en Commit-medarbejder sat på Niklas Bondestams opslag med temaet under 300 dage til, at markedet åbner. “Who might be the one holding the dynamite​”  => lader til at være dybt involveret: Project lead for over 12 years converting the Finnish gambling regulatory legal requirements into working technical solutions @commit.ficommit.ficommit.ficommit.fi                   LinkedIn              Less than 300 days to get your iGaming rocket ready for the launchpad in...    Less than 300 days to get your iGaming rocket ready for the launchpad in Finland  🇫🇮.  Contact Ubetec for expert local help with Finnish technical compliance.  Next week, you can meet us at the Finnish Gaming Event in Helsinki.

Nå, Finland er nævnt særskilt (torille), og Kevin Cheng er også særskilt nævnt som værende med på standen, og Kevin er jo “director” hos Wiser Optomed. Jeg kunne lægge det under Optomeds “digital innovation”, da de også har vundet priser i Kina. Ikke for det, der er nok af disse pladder-og-ballade-arrangementer [kissanristiäisiä], og det skal der også være. Men når Optomed meddeler, at de har vundet spilmyndighedens udbud [pelivalvonnan kilpailutuksen] i et udbud af det finske monopol-selskab, falder aktien dagen efter med en procent. Man kan roligt købe op i fred og ro, det nytter ikke noget at råbe bagefter: “gid jeg havde…”.

Optomed er vist ikke med på de messer, wiiser har mange andre jern i ilden der.

Det sker i Kina…                   LinkedIn              中国国际投资贸易洽谈会 | WISER ASIA    Tomorrow our team will be in Xiamen, to participate the 26th China International Fair for Investment & Trade (CIFIT)  (8–11 Sept), which welcomes delegates from 129 countries, 30 international organizations, 1,200+ delegations, 46 events, as well as...

Her er Juhas kommentarer til, hvordan Optomeds dattervirksomhed Ubetec Oy vandt Veikkaus Oy’s udbud.   Optomed meddelte fredag, at dattervirksomheden Ubetec Oy har vundet Veikkaus Oy’s udbud vedrørende gaming compliance-tjenester. Kontraktens samlede værdi anslås til ca. 0,9 MEUR over en toårig periode, dvs. gennemsnitligt ca. 0,45 MEUR årligt. Ifølge selskabet vil kun en lille del af kontraktens samlede værdi blive bogført som omsætning allerede i 2026. Tildelingsbeslutningen er endnu ikke endelig (klagefristen er i gang), og aftalen mellem parterne er endnu ikke underskrevet. Vi betragter nyheden som let positiv for Optomed, da den styrker Ubetecs position på Finlands åbne spillegangsmarked.                    Inderes – 7 Sep 26              Optomedin tytäryhtiö Ubetec voitti Veikkauksen kilpailutuksen - Inderes    Veikkauksen 0,9 miljoonan euron sopimusvoitto vahvistaa tytäryhtiö Ubetecin asemaa Suomen avautuvalla rahapelimarkkinalla.

Nye spilleselskaber sender millioner af euro i kassen på Veikkausliiga og klubberne. Ubetecs projekt på 0,5-1 mio. (og den efterfølgende løbende årlige omsætning) er småpenge i denne sammenhæng for en ny tilkommende. Det væsentlige er, at det hele kommer til at fungere fra starten. Det er der ikke mange selskaber, der er i stand til, endsige tilbyder en tilsvarende tjeneste på det finske marked.\n\nSuomen urheilussa odotetaan raha­peli­yhtiöiden miljoonia vesi kielellä – vain harva näkee yhteis­työssä eettisiä ongelmia | Urheilu | Yle

Optomed

Optomed Plc - Managers' transactions - Leppänen 14 August 2026 at 13.00 HelsinkiOptomed Plc - Managers' transactions - Leppänen____________________________________________Person subject to the...

Optomed Plc - Managers' transactions - Leppänen 14 August 2026 at 13.00 HelsinkiOptomed Plc - Managers' transactions - Leppänen____________________________________________Person subject to the notification requirementName: Leppänen, KristiinaPosition: Member of the Board/Deputy memberIssuer: Optomed PlcLEI: 7437009IVYWGEE4S7B77Notification type: INITIAL NOTIFICATIONReference number: 7437009IVYWGEE4S7B77_20260814094749_83____________________________________________Transaction date: 2026-08-13Venue not applicableInstrument type: SHAREISIN: FI4000410881Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVETransaction details(1): Volume: 4735 Unit price: 0.00 EURAggregated transactions(1): Volume: 4735 Volume weighted average price: 0.00 EUR<div></div>